000020.KS
Dongwha Pharm.Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 5,200.00
+0.78%Margins
Gross margin
41.8%
EBITDA margin
8.1%
EBIT margin
3.5%
Net margin
3.5%
FCF margin
-0.6%
4.6%
Return on equity
2.8%
Return on assets
3.5%
Return on invested capital
0.79x
Asset turnover
KRW 27.4B
Cash from operations
KRW 1.2K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026